Doris Mangiaracina Benbrook (Doris M Benbrook)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 13

Top Venues

Cancers

PloS one

International journal of molecular sciences

Journal of gynecologic oncology

University of Oklahoma Health Sciences Center

Loyola University Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oklahoma Health Sciences Center Oct 01 1991

United States

Professor, Co-Director Gynecologic Cancers Program, Co-Director Center for Cancer Prevention and Drug Development :: Obstetrics and Gynecology

Education History

Loyola University Medical Center

United States

PHD :: Biochemistry

Publications

Zitha Redempta Isingizwe, Laura F Mortan, Doris Mangiaracina Benbrook
Platelet and epithelial cell interations can be modeled in cell culture, and are not affected by dihomo-gamma-linolenic acid. PloS one 19 (8) (2024)
Zitha Redempta Isingizwe, Laura F Mortan, Doris Mangiaracina Benbrook
Platelet and epithelial cell interations can be modeled in cell culture, and are not affected by dihomo-gamma-linolenic acid. PloS one 19 (8) (2024)
Pouya Javadian, Chao Xu, Virginie H Sjoelund, Lindsay E Borden, Justin Garland, Doris Mangiaracina Benbrook
Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities. International journal of molecular sciences 23 (14) (2022)
Doris Mangiaracina Benbrook, James Randolph Sanders Hocker, Katherine Marie Moxley, Jay S Hanas
Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases. International journal of molecular sciences 23 (6) (2022)
Pouya Javadian, Christina Washington, Shylet Mukasa, Doris Mangiaracina Benbrook
Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity. Cancers 13 (8) (2021)
Rajani Rai, Amy L Kennedy, Zitha Redempta Isingizwe, Pouya Javadian, Doris Mangiaracina Benbrook
Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets. Cells 10 (11) (2021)
Vishal Chandra, Rajani Rai, Doris Mangiaracina Benbrook
Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer. Cancers 13 (10) (2021)
Magdalena Cybula, Lin Wang, Luyao Wang, Ana Luiza Drumond-Bock, Katherine M Moxley, Doris Mangiaracina Benbrook, Camille Gunderson-Jackson, Maria J Ruiz-Echevarria, Resham Bhattacharya, Priyabrata Mukherjee, Magdalena Bieniasz
Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research. Cancers 13 (24) (2021)
Satish K Ramraj, Sugantha P Elayapillai, Richard C Pelikan, Yan D Zhao, Zitha R Isingizwe, Amy L Kennedy, Stanley A Lightfoot, Doris Mangiaracina Benbrook
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53. International journal of cancer 147 (4) (2020)
Amy L Kennedy, Rajani Rai, Zitha Redempta Isingizwe, Yan Daniel Zhao, Stanley A Lightfoot, Doris Mangiaracina Benbrook
Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib. Cancers 12 (5) (2020)
Rajani Rai, Kathleen Gong Essel, Doris Mangiaracina Benbrook, Justin Garland, Yan Daniel Zhao, Vishal Chandra
Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer. Cancers 12 (5) (2020)
Kimberly K Leslie, Kristina W Thiel, Doris Mangiaracina Benbrook, David Mutch
The Dawning of the Age of Personalized Medicine in Gynecologic Oncology. Cancers 12 (11) (2020)
Doris Mangiaracina Benbrook, Naveena B Janakiram, Vishal Chandra, Gopal Pathuri, Venkateshwar Madka, Nicole C Stratton, Chioniso P Masamha, Cassadie N Farnsworth, Lucila Garcia-Contreras, Manolya Kukut Hatipoglu, Stan Lighfoot, Chinthalapally V Rao
Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Investigational new drugs 36 (4) (2017)
Vishal Chandra, Jong-Joo Kim, Doris Mangiaracina Benbrook, Anila Dwivedi, Rajani Rai
Therapeutic options for management of endometrial hyperplasia. Journal of gynecologic oncology 27 (1) (2015)

Doris Mangiaracina Benbrook.css-eqlu8i{font-size:small;padding-left:4px;} (Doris M Benbrook)

Publication Activity (10 Years)

Top Topics

Top Venues

Doris Mangiaracina Benbrook (Doris M Benbrook)